Nexavar Rival Offers Natco Opportunity To Build On Lenalidomide Launch
Viatris Launches First Sorafenib Generic As Teva-Partnered Revlimid Rival Lifts Natco In Q4
Executive Summary
Viatris and Natco have introduced the first US generic version of Nexavar, with the exclusive launch expected to further boost India’s Natco after a healthy financial fourth quarter that was bolstered by revenues from the firm’s recent launch of a Revlimid rival with Teva.